Work

Randomized phase II clinical trial comparing tremelimumab (CP-675,206) with best supportive care (BSC) following first-line platinum-based therapy in patients (pts) with advanced non-small cell lung cancer (NSCLC)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.8071

Authors: P. Zatloukal, D. S. Heo, K. Park, J. Kang, C. Butts, D. Bradford, S. Graziano, B. Huang, D. Healey

Institutions: SUNY Upstate Medical University, Charles University, Seoul National University Hospital, Highlands Oncology Group, Sungkyunkwan University, Catholic University of Korea

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2419443098

Cites:

Cited by: 125

Related to: 10